Investigating the clinical and cost effectiveness of 4 ELISA kits for monitoring infliximab in patients with Crohn’s disease: Protocol for a validation study

Thomas Richard Daniel Langford; Zehra Arkir; Anastasia Chalkidou; Kate Goddard; Lamprini Kaftantzi; Mark Alphonse Samaan; Peter Irving

Investigating the clinical and cost effectiveness of 4 ELISA kits for monitoring infliximab in patients with Crohn’s disease: Protocol for a validation study

Thomas Richard Daniel Langford, Zehra Arkir, Anastasia Chalkidou, Kate Goddard, Lamprini Kaftantzi, Mark Alphonse Samaan, Peter Irving

Unknown

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	JMIR research protocols
Publication status	Accepted/In press - 7 Aug 2018

Cite this

@article{3912063e44b44ced819dcb96f7408d61,

title = "Investigating the clinical and cost effectiveness of 4 ELISA kits for monitoring infliximab in patients with Crohn{\textquoteright}s disease: Protocol for a validation study",

author = "Langford, {Thomas Richard Daniel} and Zehra Arkir and Anastasia Chalkidou and Kate Goddard and Lamprini Kaftantzi and Samaan, {Mark Alphonse} and Peter Irving",

year = "2018",

month = aug,

day = "7",

language = "English",

journal = "JMIR research protocols",

issn = "1929-0748",

publisher = "JMIR Publications Inc.",

}

TY - JOUR

T1 - Investigating the clinical and cost effectiveness of 4 ELISA kits for monitoring infliximab in patients with Crohn’s disease

T2 - Protocol for a validation study

AU - Langford, Thomas Richard Daniel

AU - Arkir, Zehra

AU - Chalkidou, Anastasia

AU - Goddard, Kate

AU - Kaftantzi, Lamprini

AU - Samaan, Mark Alphonse

AU - Irving, Peter

PY - 2018/8/7

Y1 - 2018/8/7

M3 - Article

SN - 1929-0748

JO - JMIR research protocols

JF - JMIR research protocols

ER -